News | February 26, 2024
Max Healthcare to acquire land parcel in Lucknow for new hospital
The board gave in-principle approval for expansion of company's footprint in Lucknow
The board gave in-principle approval for expansion of company's footprint in Lucknow
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Sustainability is integral to Biocon's business purpose
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Subscribe To Our Newsletter & Stay Updated
